显性负性突变体 dominant negative mutant ; dominant negative TCF ; DNTCF
显性失活突变体 dominant inactive mutant
的显性负性突变体 dominant negative TCF ; RIP3-dominantnegative ; DNTCF
显性阴性突变体 dominant negative mutation ; dominant negative mutants ; DNM
技术和显性阴性突变体 dominant negative mutation ; DNM
显性激活突变体 Dominant active mutant
此外，激发标签技术得到的突变体通常为显性遗传，其突变的性状可在转基因的T1代表现出来，为目标突变体的筛选带来了很大的便利。
Moreover, activation tagging mutants usually are dominant, so their phenotypes can be observed in the T1 generation, which is very helpful to screen the mutants on purpose.
目的探索H BV作为基因治疗载体的可能性及检验HBV点突变表达显性阴性突变体抗hbv的作用。
Objective to explore the possibility of using HBV as a gene delivery vector, and to test the anti-HBV effects by intracellular expression of dominant negative mutants of core protein.
应用推荐